As FDA-approved AI software continues to proliferate in radiology—well more than 150 products to date and rising—a trio of Yale radiologists has compiled a status report focused on AI applications available to, specifically, emergency radiology.

AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.

Researchers have developed a novel cardiovascular MRI protocol as an option to the invasive gold standard, endomyocardial biopsy, for monitoring heart-transplant patients at risk of suffering organ rejection.

The reception was similarly warm among parents toward AI used to assess a child’s need for antibiotics or bloodwork.

Two European studies illustrate opportunities and challenges presented by the growing appeal of point-of-care ultrasound to primary care practices.  

A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

Iodinated contrast is most widely used in patients undergoing CT studies for, in descending order, abdominopelvic, chest, head/neck and brain indications.